Skip to main content
. 2023 Jun 20;22:75. doi: 10.1186/s12944-023-01844-w

Table 2.

Participant characteristics

Placebo Choline P-value
Mean  ±  SE Mean  ±  SE
Number of subjects 21 (11: 10) 20 (12: 8)
(Male: Female)
Age (y) 66  ±  1.22 64.7  ±  0.67  > 0.05
Height (cm) 160  ±  1.72 163  ±  1.62  > 0.05
Body weight (kg) 60.1  ±  2.29 60.4  ±  2.64  > 0.05
BMI 23.4  ±  0.75 22.3  ±  0.65  > 0.05
Systolic blood pressure (mmHg) 121  ±  3.67 125  ±  3.47  > 0.05
Diastolic blood pressure (mmHg) 76.7  ±  2.67 76.8  ±  2.81  > 0.05
Pulse (/m) 79.7  ±  2.46 78.1  ±  2.04  > 0.05
MMSE-J 28.8  ±  0.21 28.9  ±  0.24  > 0.05
GDS-S-J 1.33  ±  0.3 1.7  ±  0.35  > 0.05
Cognitrax Verbal memory 52.7  ±  1.11 50.9  ±  1.42  > 0.05
Psychomotor speed 162  ±  3.66 160  ±  5.7  > 0.05
Processing Speed 53  ±  1.62 55.8  ±  1.83  > 0.05
Simple Attention 39.8  ±  0.11 39.4  ±  0.4  > 0.05
Motor Speed 108  ±  2.84 104  ±  4.98  > 0.05
Plasma free choline level (μM) 14.3  ±  0.59 14.3  ±  0.67  > 0.05
Egg consumption (n/week) 2.84  ±  0.44 3.39  ±  0.39  > 0.05

Mean ± SE of 20 or 21 subjects. The P-values are from the Student’s t-test, comparing values in the placebo and choline groups